GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. – Trademark Portfolio

Entity Type: 99

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KOOLINE. The owner is based in GUANGZHOU, GUANGDONG.

RM 802, BLDG 1, NO.30, MINGZHU AVE SOUTH

GUANGZHOU, GUANGDONG 510931 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOOLINE
KOOLINE
Registered 2020

Trademark Classifications

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. have?

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. file in?

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD.'s most well-known trademarks?

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD.'s registered trademark portfolio includes well-known marks such as KOOLINE. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD.'s trademark registration success rate?

GUANGZHOU KANGLING MEDICAL PRODUCTS CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.